Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 7 Jan 2019 |
| Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine | 21 Dec 2018 |
| Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program | 13 Nov 2018 |
| Bavarian Nordic Announces Interim Results for the First Nine Months of 2018 | 9 Nov 2018 |
| Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers | 2 Nov 2018 |
| Henrik Juuel Joins Bavarian Nordic as Chief Financial Officer | 1 Nov 2018 |